tiprankstipranks
Trending News
More News >
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market

Rapport Therapeutics, Inc. (RAPP) Cash flow

Compare
115 Followers

Rapport Therapeutics, Inc. Cash Flow

RAPP's free cash flow for Q3 2025 was $-17.60M. For the 2025 fiscal year, RAPP's free cash flow was decreased by $-38.42M and operating cash flow was $-17.46M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22
Operating Cash Flow
$ -64.83M$ -27.18M$ -3.24M
Investing Cash Flow
$ -170.14M$ -78.86M$ -5.28M
Financing Cash Flow
$ 221.63M$ 145.14M$ 39.69M
End Cash Position
$ 56.91M$ 70.25M$ 31.16M
Free Cash Flow
$ -67.23M$ -28.82M$ -3.53M
Currency in USD

Rapport Therapeutics, Inc. Cash Flow